{"id":116,"date":"2020-11-30T10:33:40","date_gmt":"2020-11-30T10:33:40","guid":{"rendered":"http:\/\/www.ull.es\/institutos\/instituto-tecnologias-biomedicas\/?page_id=116"},"modified":"2021-10-18T11:32:18","modified_gmt":"2021-10-18T11:32:18","slug":"programmes-groups-and-research-lines","status":"publish","type":"page","link":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/programmes-groups-and-research-lines\/","title":{"rendered":"Programmes, groups and research lines"},"content":{"rendered":"<p>[vc_row full_width=\u00bbstretch_row_content\u00bb el_class=\u00bbprincipio-marcha\u00bb][vc_column css=\u00bb.vc_custom_1588939369209{padding-top: 40px !important;}\u00bb][vc_custom_heading text=\u00bbProgrammes, groups and research lines\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23ffffff\u00bb use_theme_fonts=\u00bbyes\u00bb css_animation=\u00bbfadeInDownBig\u00bb][\/vc_column][\/vc_row][vc_row full_width=\u00bbstretch_row_content\u00bb equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2&#8243; css=\u00bb.vc_custom_1588936329456{padding-top: 5% !important;padding-right: 10% !important;padding-bottom: 5% !important;padding-left: 10% !important;background-color: #f2f2f2 !important;}\u00bb][vc_column_text]The research groups at the ITB are comprised of teaching and research staff who come together to study specific research lines of interest. It is understood that the members of a group collaborate effectively, participating in common projects, as witnessed by the record of joint publications of sufficient quality and volume to satisfy the demands of the Executive Commission. Every research group must maintain a project that receives significant external funding, led by a researcher with a clear trajectory in the particular area of research, although emerging groups applying for public competitive calls for the first time may be considered as special cases. Following the strategic analyses of the past few years, the activities at the ITB were recently restructured into four research programmes (see below), with a view to applying for status as a \u201cMar\u00eda de Maeztu\u201d Unit of Excellence in the 2019 call.<\/p>\n<p>In addition, the Institute also integrates research groups that work in complementary areas and that have the potential to collaborate in developing research lines, or that provide services to members of the Institute, such as laboratories and associated units from the Biomedical Innovation Platform.<\/p>\n<p>In the description of each group, all the members considered formal members of the Institute are listed, including PIs, Associated Researchers and researchers in trainning. Each group also includes external collaborators and assistant researchers who are not formal members of the Institute.[\/vc_column_text][\/vc_column][vc_column width=\u00bb1\/2&#8243; css=\u00bb.vc_custom_1606731534693{background: #e5e5e5 url(http:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-content\/uploads\/sites\/17\/2020\/11\/fondo-cabecera-01.jpg?id=117) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00bb][vc_empty_space height=\u00bb500px\u00bb][\/vc_column][\/vc_row][vc_row full_width=\u00bbstretch_row_content\u00bb equal_height=\u00bbyes\u00bb][vc_column css=\u00bb.vc_custom_1588945461556{background-color: #f2f2f2 !important;}\u00bb][vc_column_text]<\/p>\n<h2 style=\"text-align: center;\">Programmes<\/h2>\n<p>[\/vc_column_text][vc_tta_accordion active_section=\u00bb0&#8243; css_animation=\u00bbfadeInDown\u00bb collapsible_all=\u00bbtrue\u00bb][vc_tta_section title=\u00bbGenetic &amp; rare diseases\u00bb tab_id=\u00bbgenetic-rare-diseases\u00bb][vc_empty_space height=\u00bb20px\u00bb][vc_column_text css=\u00bb.vc_custom_1616071287069{padding-right: 3% !important;padding-left: 3% !important;}\u00bb]This programme has been designed based on the history and geographical circumstances of the Canary Islands. The current genome of the Canarian population is inherited from the aboriginal people of North Africa and from the European population since the 15th century, making it a unique worldwide genome. In addition, there are a number of pathologies seen in the islands that exhibit a genetic component influenced by the insular concept, due to a founder effect and the lack of infrastructures that in the past favored endogamy. The research groups involved in this programme focus on studying the molecular bases of cancer and rare metabolic diseases. Cancer research is aimed at prevention, diagnosis, the identification of the biological causes and the development of effective treatments, with the ultimate goal that this serious health problem should become a chronic condition as opposed to a fatal one. On the other hand, although individual rare diseases affect only a limited fraction of the population (less than 2,000 people in Europe), the number of different diseases is very high (more than 5,000) and the total number of patients exceeds 30 million in the European Union. This arm of the programme, pursues medium and long-term goals, such as the development of personalised medicines and a reinforcement of the collaborations with industry.<\/p>\n<h4>Groups ( click for more information)<\/h4>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/checkpoint-response-to-dna-damage-and-human-deseases\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Checkpoint response to DNA damage and human deseases<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/replicative-stress-and-tumorigenesis\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Replicative stress and tumorigenesis<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/genomics-and-health\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Genomics and health<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/genomic-instability-and-cancer\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Genomic instability and cancer<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/molecular-pathology-of-rare-and-metabolic-diseases\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Molecular pathology of rare and metabolic diseases <\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/genetic-variation-and-disease\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Genetic variation and disease<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/developmental-biology\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Developmental biology <\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_empty_space height=\u00bb20px\u00bb][\/vc_tta_section][vc_tta_section title=\u00bbChronic &amp; age-related diseases\u00bb tab_id=\u00bbChronic-age-related-diseases\u00bb][vc_column_text css=\u00bb.vc_custom_1616141867025{padding-right: 3% !important;padding-left: 3% !important;}\u00bb]This programme is dedicated to research into the biological basis of the main human diseases and to finding new therapies for these. Bearing in mind that the severity of most of these conditions increases with age and given the ageing of the population in the EU, the economic impact of these pathologies is clearly very high. The majority of age-related diseases have a complex development and they affect different body systems, requiring a preventive strategy, a global therapeutic approach and a stricter control of lifestyle.<\/p>\n<h4>Groups ( click for more information)<\/h4>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/chronic-kidney-disease-diabetes-and-kidney-transplant-complications\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Chronic kidney disease, diabetes and kidney transplant complications<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/inflammatory-and-neoplastic-disease-of-the-gastrointestinal-tract-prevalent-liver-diseases\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Inflammatory and neoplastic disease of the gastrointestinal tract, Prevalent Liver Diseases<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/physiopathology-of-mineralocorticoids\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Physiopathology of mineralocorticoids<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/kidney-and-cardiovascular-disease-research\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Kidney and cardiovascular disease research<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/inflammatory-response-and-tissue-damage-in-rheumatoid-arthritis\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Inflammatory response and tissue damage in rheumatoid arthritis<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_empty_space height=\u00bb20px\u00bb][\/vc_tta_section][vc_tta_section title=\u00bbDrug development and target identification\u00bb tab_id=\u00bbDrug-development-and-target-identification\u00bb][vc_column_text css=\u00bb.vc_custom_1634556304143{padding-right: 3% !important;padding-left: 3% !important;}\u00bb]This programme has recently been created to promote the development of projects focused on the search for new compounds with therapeutic potential, new drug delivery systems and the identification of pharmacological targets. This programme brings together three research teams that use complementary approaches and numerous collaborations with groups from the other three programmes of the Institute.<\/p>\n<h4>Groups (click for more information)<\/h4>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/drug-release-systems\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Drug release systems<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/mathematical-modelling-of-biological-systems-and-human-diseases\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Mathematical modelling of biological systems and human diseases<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/biolab-phenotypic-drug-discovery\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">BioLab (\u201cPhenotypic drug discovery\u201d)<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_tta_section][vc_tta_section title=\u00bbNeurobiology and brain-related diseases\u00bb tab_id=\u00bbNeurobiology-and-brain-related-diseases\u00bb][vc_column_text css=\u00bb.vc_custom_1634556309982{padding-right: 3% !important;padding-left: 3% !important;}\u00bb]This programme integrates groups working on the biology and pathology of the Nervous System, specifically: neurodegenerative diseases, the molecular and cellular basis of neuronal vulnerability, the development of animal models to study the genetic basis of neurodegeneration, and the analysis of global brain function and the biological basis of cognition. The role of specific membrane proteins (ion channels and transporters) and signalling molecules in different excitable cells is studied at the cellular and molecular level using electrophysiological, molecular and morphological techniques. An emerging platform within this programme is dedicated to developing novel animal models for neurodegenerative diseases. Several research lines centre on the analysis of the human brain as a whole, using electrophysiological and neuroimaging techniques. Together, these studies provide a holistic approach to the human nervous system, which will contribute to the search for new therapies to combat neurodegenerative diseases.<\/p>\n<h4>Groups (click for more information)<\/h4>\n<h4>A. Molecular and Cellular Neurobiology<\/h4>\n<ul class=\"grupos\">\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/molecular-basis-of-human-channelopathies-molcan\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Molecular basis of human channelopathies (MOLCAN)<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/molecular-mechanisms-in-neurodegeneration\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\"> Molecular mechanisms in neurodegeneration<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/neurodegenerative-animal-models\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Neurodegenerative animal models<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/vulnerability-and-neuronal-plasticity\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Vulnerability and neuronal plasticity<\/a><\/li>\n<\/ul>\n<h4>B. Clinical and cognitive neuroscience<\/h4>\n<ul>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/bilingualism-and-emotion-cognition-coupling\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Bilingualism and emotion-cognition coupling <\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/brain-imaging-laboratory\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Brain imaging laboratory<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/electrical-engineering-and-bioengineering\/\" target=\"_blank\" rel=\"noopener\">Electrical engineering and bioengineering<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/cognitive-and-psycholinguistic-neuroscience\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\">Cognitive and psycholinguistic neuroscience<\/a><\/li>\n<li><a href=\"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/neurochemistry-and-neuroimagen\/\" target=\"_blank\" rel=\"noopener noreferrer\" target=\"_blank\" rel=\"noopener\"> Neurochemistry and Neuroimagen<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][vc_empty_space height=\u00bb120px\u00bb][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row full_width=\u00bbstretch_row_content\u00bb el_class=\u00bbprincipio-marcha\u00bb][vc_column css=\u00bb.vc_custom_1588939369209{padding-top: 40px !important;}\u00bb][vc_custom_heading text=\u00bbProgrammes, groups and research lines\u00bb font_container=\u00bbtag:h2|text_align:center|color:%23ffffff\u00bb use_theme_fonts=\u00bbyes\u00bb css_animation=\u00bbfadeInDownBig\u00bb][\/vc_column][\/vc_row][vc_row full_width=\u00bbstretch_row_content\u00bb equal_height=\u00bbyes\u00bb][vc_column width=\u00bb1\/2&#8243; css=\u00bb.vc_custom_1588936329456{padding-top: 5% !important;padding-right: 10% !important;padding-bottom: 5% !important;padding-left: 10% !important;background-color: #f2f2f2 !important;}\u00bb][vc_column_text]The research groups at the ITB are comprised of teaching and research staff who come together to study specific research lines of interest. It is understood that the&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-no-title.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/pages\/116"}],"collection":[{"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":10,"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":408,"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/pages\/116\/revisions\/408"}],"wp:attachment":[{"href":"https:\/\/www.ull.es\/institutos\/institute-biomedical-technologies\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}